FIND Stroke Recovery - A Longitudinal Study
Launched by GÖTEBORG UNIVERSITY · Jan 24, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The FIND Stroke Recovery study is looking at how people recover after having a stroke, which can cause problems with movement, thinking, speaking, and even feelings. The researchers want to understand how different patients recover over time and what factors, known as biomarkers, might help predict recovery outcomes. This study is particularly important because it aims to fill in the gaps about how recovery happens and how long it might take for different people.
To participate in this study, you need to be between the ages of 65 and 74 and have experienced your first stroke, either an ischemic stroke (the most common type caused by a blocked blood vessel) or a hemorrhagic stroke (caused by bleeding in the brain). If you have had significant health issues before your stroke or are dealing with severe illnesses, you may not be eligible. Participants can expect to be monitored over time to track their recovery and any associated changes in biomarkers, helping to build a clearer picture of stroke recovery for future patients.
Gender
ALL
Eligibility criteria
- • Investigators enrol patients presenting with first-ever ischemic stroke or intracerebral haemorrhage admitted to the stroke units at the Sahlgrenska University Hospital in Gothenburg, Sweden.
- The inclusion criteria are:
- • • first-ever acute ischemic stroke; or intracerebral hemorrhage.
- The exclusion criteria are:
- • pre-stroke mRS score of ≥3;
- • severe neurodegenerative disease, cerebral neoplasm or terminal illness; and
- • patients considered unlikely to be able to participate in or to understand and/or comply with study procedures during follow-up visits at the hospital.
About Göteborg University
Göteborg University, a leading academic institution in Sweden, is committed to advancing healthcare through innovative research and clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and social sciences, to address pressing health challenges. By sponsoring clinical trials, Göteborg University aims to contribute to the development of new therapies and improve patient outcomes, while adhering to the highest ethical standards and regulatory requirements. Their dedication to rigorous scientific inquiry and community engagement positions them as a pivotal player in the global health research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Patients applied
Trial Officials
Christina Jern, MD, PhD
Principal Investigator
Inst. of Biomedicine, the Sahlgrenska Academy, Univ. of Gothenburg
Turgut Tatlisumak, MD, PhD
Principal Investigator
Dept. of Neurology, Sahlgrenska Univ. Hosp., Gothenburg
Katarina Jood, MD, PhD
Principal Investigator
Dept. of Neurology, Sahlgrenska Univ. Hosp., Gothenburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials